Abstract
Novel drug delivery systems, such as solid lipid nanoparticles (SLN), have been proposed to reduce retinoic acid (RA)-induced skin irritation. However, one question still remains: could it be accomplished without reducing efficacy? To evaluate this question the comedolytic effects and epidermal thickening of RA-loaded SLN were compared to the conventional RA formulations (gel or cream), as well as the potential of these formulations to induce skin irritation. The comedolytic effects and epidermal thickening of these formulations, both containing RA at 0.01 or 0.05%, were investigated in a rhino mouse model, while the studies of RA-induced skin irritation were evaluated through rabbit skin irritation tests and in the rhino mouse model. RA-loaded SLN, as compared to the placebo, produced a comedolytic effect with a significant reduction of the utricle diameter, which proved to be similar to that observed for marketed gels or creams regardless of the RA concentration. RA formulations (SLN or marketed cream) also induced an epidermal proliferation leading to a thickened epidermis in treated animals. In both animals studied (rhino mice and rabbits), the RA-loaded SLN, when compared to conventional formulations, promoted a significant reduction in RA-induced skin irritation (erythema and scaling). Then, RA-loaded SLN represents an interesting alternative to reduce RA-induced skin irritation without reducing efficacy, and constitutes an innovative approach for the topical treatment of acne with RA.
Similar content being viewed by others
References
Bernerd F, Démarchez M, Ortonne JP, Czernielewski J (1991) Sequence of morphological events during topical application of retinoic acid on the rhino mouse skin. Br J Dermatol 125(5):419–425
Bhambri S, Del Rosso JQ, Bhambri A (2009) Pathogenesis of acne vulgaris: recent advances. J Drugs Dermatol 8(7):615–618
Castro GA, Ferreira LAM (2008) Novel vesicular and particulate drug delivery systems for topical treatment of acne. Expert Opin Drug Deliv 5(6):665–679
Castro GA, Oréfice RL, Vilela JMC, Andrade MS, Ferreira LAM (2007) Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. J Microencapsul 24(5):395–407
Castro GA, Coelho AL, Oliveira CA, Mahecha GA, Oréfice RL, Ferreira LAM (2009) Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. Int J Pharm 381(1):77–83
Date AA, Naik B, Nagarsenker MS (2006) Novel drug delivery systems: potential in improving topical delivery of antiacne agents. Skin Pharmacol Physiol 19(1):2–16
Draize JH, Woodard G, Calvery HO (1944) Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 82:377–390
Ellis CN, Millikan LE, Smith EB, Chalker DM, Swinyer LJ, Katz IH, Berger RS, Mills OH Jr, Baker M, Verschoore M, Loesche C (1998) Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in topical treatment of acne vulgaris. Br J Dermatol 139(Suppl 52):41–47
Fisher GJ, Talwar HS, Xiao JH, Datta SC, Reddy AP, Gaub MP, Rochette-Egly C, Chambon P, Voorhees JJ (1994) Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J Biol Chem 269(32):20629–20635
Fluhr JW, Vienne MP, Lauze C, Dupuy P, Gehring W, Gloor M (1999) Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions. Dermatology 199(Suppl 1):57–60
Gollnick H, Schramm M (1998) Topical drug treatment in acne. Dermatology 196(1):119–125
Gollnick H, Cunliffe W, Berson D et al (2003) Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 49(Suppl 1):S1–S37
Jenning V, Gohla SH (2001) Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsul 18(2):149–158
Jírová D, Basketter D, Liebsch M, Bendová H, Kejlová K, Marriott M, Kandárová H (2010) Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data. Contact Dermatitis 62(2):109–116
Kang S (2005) The mechanism of action of topical retinoids. Cutis 75(Suppl 2):10–13
Kim H, Kim N, Jung S, Mun J, Kim J, Kim B, Lee J, Ryoo H, Jung H (2010) Improvement in skin wrinkles from the use of photostable retinyl retinoate: a randomized controlled trial. Br J Dermatol 162(3):497–502
Kim BH, Lee YS, Kang KS (2003) The mechanism of retinol-induced irritation and its application to anti-irritant development. Toxicol Lett 146(1):65–73
Lehmann HP, Robison KA, Andrews JS, Holloway V, Goodman SN (2002) Acne therapy: a methodologic review. J Am Acad Dermatol 47(2):231–240
Mandawgade SD, Patravale VB (2008) Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm 363(1–2):132–138
Nakano K, Kiyokane K, Benvenuto-Andrade C, González S (2007) Real-time reflectance confocal microscopy, a noninvasive tool for in vivo quantitative evaluation of comedolysis in the rhino mouse model. Skin Pharmacol Physiol 20(1):29–36
Sakuta T, Kanayama T (2005) Comedolytic effect of a novel RARgamma-specific retinoid, ER36009: comparison with retinoic acid in the rhino mouse model. Eur J Dermatol 15(6):459–464
Shah KA, Date AA, Joshi MD, Patravale VB (2007) Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 345(1–2):163–171
Thiboutot D, Gollnick H, Bettoli V et al (2009) New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 60(Suppl 5):S1–S50
Thielitz A, Gollnick H (2008) Topical retinoids in acne vulgaris: update on efficacy and safety. Am J Clin Dermatol 9(6):369–381
Varani J, Fligiel H, Zhang J, Aslam MN, Lu Y, Dehne LA, Keller ET (2003) Separation of retinoid-induced epidermal and dermal thickening from skin irritation. Arch Dermatol Res 295(6):255–262
Varani J, Fay K, Perone P (2007) MDI 301, a non-irritating retinoid, induces changes in human skin that underlie repair. Arch Dermatol Res 298(9):439–448
Webster GF (1998) Topical tretinoin in acne therapy. J Am Acad Dermatol 39(2 Pt 3):S38–S44
Zheng P, Gendimenico GJ, Mezick JA, Kligman AM (1993) Topical all-trans retinoic acid rapidly corrects the follicular abnormalities of the rhino mouse. An ultrastructural study. Acta Derm Venerol 73(2):97–101
Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, Rosenfield R (2005) What is the pathogenesis of acne? Exp Dermatol 14(2):143–152
Acknowledgments
This study was supported by “Minas Gerais State Agency for Research and Development” (FAPEMIG, Brazil).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Castro, G.A., Oliveira, C.A., Mahecha, G.A.B. et al. Comedolytic effect and reduced skin irritation of a new formulation of all-trans retinoic acid-loaded solid lipid nanoparticles for topical treatment of acne. Arch Dermatol Res 303, 513–520 (2011). https://doi.org/10.1007/s00403-011-1130-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-011-1130-3